These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 848141)

  • 41. Plasma exchange in the successful treatment of drug-induced renal disease.
    Swainson CP; Thomson D; Short AI; Winney RJ
    Nephron; 1982; 30(3):244-9. PubMed ID: 7099337
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Lipoid nephrosis of toxic origin. 2 cases].
    Belghiti D; Patey O; Berry JP; Antelin C; Hirbec G; Lagrue G
    Presse Med; 1986 Nov; 15(39):1953-5. PubMed ID: 2947217
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Nephrotic syndrome with minimal glomerular lesions during treatment with D-penicillamine].
    Herve JP; Leguy P; Cledes J; Leroy JP
    Nouv Presse Med; 1980 Oct; 9(38):2847. PubMed ID: 7443414
    [No Abstract]   [Full Text] [Related]  

  • 44. [Morphology and pathogenesis of penicillamine-induced nephropathy].
    Henzgen S; Waldmann G
    Zentralbl Allg Pathol; 1983; 128(1-2):53-61. PubMed ID: 6637187
    [TBL] [Abstract][Full Text] [Related]  

  • 45. D-penicillamine-induced crescentic glomerulonephritis and antimyeloperoxidase antibodies in a patient with scleroderma. Case report and review of the literature.
    Karpinski J; Jothy S; Radoux V; Levy M; Baran D
    Am J Nephrol; 1997; 17(6):528-32. PubMed ID: 9426850
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Extramembranous glomerulonephritis induced by D-penicillamine. Description of a case].
    Miguel Donderis A; Sánchez Vegazo I; Gómez Campdera FJ; Gallego JL; Fernández Fernández J; Sanz Guajardo D; Botella J
    Rev Clin Esp; 1981 Jan; 160(2):137-8. PubMed ID: 7209061
    [No Abstract]   [Full Text] [Related]  

  • 47. [Pathohistologic and ultrastructural features of drug-induced membranous glomerulonephritis].
    Pospishil' IuA
    Arkh Patol; 1996; 58(5):52-6. PubMed ID: 9005826
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Membranous nephropathy. Long-term follow-up and association with neoplasia.
    Row PG; Cameron JS; Turner DR; Evans DJ; White RH; Ogg CS; Chantler C; Brown CB
    Q J Med; 1975 Apr; 44(174):207-39. PubMed ID: 1178811
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Phenylbutazone-induced systemic vasculitis with crescentic glomerulonephritis.
    Leung AC; McLay A; Dobbie JW; Jones JM
    Arch Intern Med; 1985 Apr; 145(4):685-7. PubMed ID: 3157355
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of D-penicillamine administration to rats, induction of renal changes: preliminary communication.
    Batsford SR; Rohrbach R; Riede UN; Sandritter W; Kluthe R
    Clin Nephrol; 1976 Sep; 6(3):394-7. PubMed ID: 991466
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Case of the development of the nephrotic syndrome in a female patient with systemic scleroderma against a D-penicillamine treatment background].
    Grebeneva LS
    Vopr Revm; 1979; (1):51-3. PubMed ID: 425416
    [No Abstract]   [Full Text] [Related]  

  • 52. [Kidney damage caused by drugs].
    Girndt J
    Z Hautkr; 1986 Feb; 61(3):113-7. PubMed ID: 3953133
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Extra-capillary glomerulonephritis induced by D-penicillamine therapy].
    Marlier S; Gisserot O; Yao N; Hecht M; Paris JF; Carli P; Chagnon A
    Presse Med; 1999 Apr; 28(13):689-90. PubMed ID: 10228478
    [No Abstract]   [Full Text] [Related]  

  • 54. Nephrotic syndrome associated with lithium therapy.
    Alexander F; Martin J
    Clin Nephrol; 1981 May; 15(5):267-71. PubMed ID: 7249424
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiglomerular basement membrane glomerulonephritis following D-penicillamine-associated nephrotic syndrome.
    Bindi P; Gilson B; Aymard B; Noël LH; Wieslander J
    Nephrol Dial Transplant; 1997 Feb; 12(2):325-7. PubMed ID: 9132654
    [No Abstract]   [Full Text] [Related]  

  • 56. IgM nephropathy associated with penicillamine.
    Rehan A; Johnson K
    Am J Nephrol; 1986; 6(1):71-4. PubMed ID: 3963062
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nephrotic syndrome after treatment with D-penicillamine.
    Felts JH; King JS; Boyce WH
    Lancet; 1968 Jan; 1(7532):53-4. PubMed ID: 4169108
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical observations on treatment of alkylmercury poisoning in hospital patients.
    Bakir F; Al-Khalidi A; Clarkson TW; Greenwood R
    Bull World Health Organ; 1976; 53 Suppl(Suppl):87-92. PubMed ID: 1086170
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Domestic metallic mercury poisoning.
    McNeil NI; Issler HC; Olver RE; Wrong OM
    Lancet; 1984 Feb; 1(8371):269-71. PubMed ID: 6143006
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug-induced nephropathies.
    Burry HC
    Proc R Soc Med; 1973 Sep; 66(9):897-900. PubMed ID: 4805093
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.